Transforming growth factor beta in breast cancer: another new trick for the old dog
Kun-Hui Lu, Shom Goel
Immunology and Cell Biology | WILEY | Published : 2020
Two recent papers from the laboratory of Professor Ming Li demonstrate that inhibition of transforming growth factor β specifically in CD4+ T cells can suppress tumor growth through an unanticipated mechanism.
Shom Goel is a paid advisor for Eli Lilly, G1 Therapeutics, Pfizer, Novartis. Shom Goel is sponsored by Eli Lilly for clinical research and laboratory research. Shom Goel and Kun-Hui Lu are sponsored by G1 Therapeutics for laboratory research.